Showing 1 posts of 1 posts found.
GlaxoSmithKline is looking to make more than £7 billion by selling off its ageing portfolio of established drugs. This is …
From lab breakthrough to NHS treatment: Getting innovative therapies to patients
Five Facts about NHS and primary care
Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.
AI in pharma: From lab development to patient impact
Back to basics: X-ray inspection in pharmaceutical and medical device production